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doi:10.1016/j.jmii.2011.12.027Background/Purpose: Cryoglobulinemic vasculitis is a systemic vasculitis resulting from circu-
lating immune complex deposition in the small vessels and is characterized by variable clinical
features, including purpura, Raynaud’s syndrome, ulcerations, arthralgia, glomerulonephritis,
and peripheral neuropathy. Cryoglobulinemia can also result from hepatitis C virus (HCV) infec-
tion. The clinical spectrum and associated or underlying diseases of cryoglobulinemia in
different age groups is not well understood. This study investigated the demographic, clinical,
serologic features, and associated or underlying diseases in children and adult patients with
cryoglobulinemia.
Methods: The retrospective study included 114 patients (18 children, 96 adults) who presented
with cryoglobulinemia between 2000 and 2010 at the Chang Gung Memorial Hospital. Their
medical records were reviewed and serological and virologic assessments were analyzed.
Results: In this group of patients, children had a significantly higher prevalence of prolonged
fever (16.7% vs. 3.13%; pZ 0.018), arthralgia (66.67% vs. 16.67%; p < 0.001), arthritis
(66.67% vs. 15.63%; p < 0.001) and cutaneous involvement (77.78% vs. 50%; pZ 0.03)
compared with adults. Both the adult and children groups had a greater frequency of hepatitis
B virus (HBV) infection (20.8% and 5.6%, respectively), than HCV infection (12.5% and 0%,
respectively).ediatric Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital
hang Gung University, Taoyuan, Taiwan
.org.tw (K.-W. Yeh).
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60 Y.-T. Liou et al.Conclusions: Children with cryoglobulinemia had a significantly higher prevalence of prolonged
fever, arthralgia, arthritis and cutaneous involvement compared with adults.
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The presence of one or more immunoglobulins that
precipitate below core body temperatures and re-dissolve
on re-warming is termed “cryoglobulinemia”.1,2 Cry-
oglobulinemia has been described in a wide variety of
diseases, including malignancies, infections, and systemic
autoimmune diseases in adults.3e6 When there is no
demonstrable associated or underlying disease, the condi-
tion is called “essential cryoglobulinemia”.7,8 Hepatitis C
virus (HCV) is one of the main causative pathogens in
Caucasian mixed cryoglobulinemia (MC).9,10 Hepatitis B
virus (HBV) is the major hepatitis virus in the Far East.11 It is
conceivable that the most prevalent infectious etiologies of
cryoglobulinemia between the East and West are different.
The clinical manifestations of cryoglobulinemia in Cauca-
sian adults are diverse. Cutaneous features were the most
frequent presentations; purpura on lower limbs was the
most common symptom (w80e90%).2,9 Other clinical
manifestations included arthralgia (40e98%), muscle
weakness (80e90%), peripheral neuropathy (20e84%), liver
involvement (58e77%), renal involvement (20e60%), Ray-
naud phenomenon (25e50%), and ulcers (10e40%) .2,9,12
Cryoglobulinemia is rarely reported in the pediatric
literature. A few studies investigated the associated or
underlying diseases of children’s cryoglobulinemia, such as
Schistosoma haematobium infection13 and essential cry-
oglobulinemia.14,15 The clinical symptoms of children’s
cryoglobulinemia were fever, arthralgia, rash, mem-
branoproliferative glomerulonephritis in one case report14
and fever, and bluish black discoloration of hands and
feet in another report.15 According to the literature review,
we considered that the different age groups may have
distinct clinical features and associated or underlying
diseases. To our knowledge, there have been no reports, so
far, that have assessed the clinical dissimilarities and
associated diseases between children and adults.
The present retrospective study evaluated the charac-
teristics of pediatric cryoglobulinemia and compared the
epidemiologic and clinicoserologic features, and associated
or underlying diseases between children and adult groups in
a large series of patients with cryoglobulinemia in Taiwan.Materials and methods
Study subjects
We reviewed the medical records and enrolled patients
that had cryoglobulinemia and clinical manifestations at
Chang Gung Memorial Hospital from January 2000 to
October 2010. The definition of the mean age at onset was
the age of the patient when they first presented thecommon clinical symptoms of cryoglobulinemia. The defi-
nition of the mean age at diagnosis was the time when the
patient had clinical features and had a confirmed serologic
diagnosis.
Analysis of associated or underlying factors
In order to explore the relationship between the clinical
symptoms and different associated or underlying disorders,
we identified the most common clinical features and asso-
ciated diseases. Viral infection included HBV, HBC, Epstein-
Barr virus, and parvovirus. Autoimmune diseases were
diagnosed based on the following criteria: (1) primary Sjog-
ren syndrome (SS) according to the preliminary diagnostic
criteria for SS proposed by the European Community Study
Group16 before 2002 and the revised diagnostic criteria for
SS proposed by the American-European Consensus Group17
after 2002; (2) systemic lupus erythematosus (SLE) accord-
ing to the 1997 revised criteria of the American College of
Rheumatology;18 (3) rheumatoid arthritis (RA) using the
1987 criteria of the American College of Rheumatology;19 (4)
juvenile idiopathic arthritis (JIA) as defined by the Interna-
tional League of Associations for Rheumatology criteria;20
(5) polymyositis-dermatomyositis using the criteria of
Bohan and Peter;21 and (6) primary antiphospholipid
syndrome as defined by the revised classification criteria.22
Hematologic malignancies were confirmed by the clinical
findings and biopsies of lymph nodes and/or bone marrow.
Essential cryoglobulinemia was considered in those cases in
which no infectious, autoimmune, or hematologic disease
was found.
Definition of clinical features
The clinical symptoms evaluated in our protocol were
defined as follows: (1) prolonged fever meant axillary
temperature < 38C for at least 1 week; (2) arthralgia
meant joint pain. Arthritis indicated joint swelling or two
or more of erythema, local heat, tenderness or a limited
range of motion; (3) cutaneous involvement contained
papule, macule or gangrene; (4) peripheral neurologic
manifestations included paresthesia, numbness, and/or
motor defects of the lower extremities; (5) kidney involved
proteinuria or altered urinalysis (hematuria, red blood cell
casts), or raised serum creatinine. Glomerular injury diag-
nosed by renal biopsy included membranoproliferative
glomerulonephritis, mesangial proliferative glomerulone-
phritis, and segmentary and focal glomerulonephritis; (6)
gastrointestinal involvement covered severe abdominal
pain, elevated liver enzymes with/without echographic
and/or histologic features of chronic hepatitis, cirrhosis;
(7) arterial or venous thrombosis confirmed by clinical and
color Doppler or computed tomography angiogram.
Table 2 Comparisons of clinical characteristics between
the children and adult control groups
Event, n (%) Children Adult group, p
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Cryoglobulin was detected by double immunodiffusion. HCV
antigen, anti-HCV, HBV surface antigen (HBsAg), and anti-
HBV antibodies were measured by Roche COBAS TaqMan,
Mannheim, Germany. Antinuclear antibodies were identified
by indirect immunofluorescence using ASP1200, DiaSorin,
Stillwater, MN, USA. Anticardiolipid antibodies, anti-
extractable nuclear antigen, and antineutrophil cytoplasm
antibodies were detected by Uni-CAP 100, Phadia, Uppsala,
Sweden. Parvovirus B19 IgMwas detected by RIDASCREEN, R-
BiopharmAG, Darmstadt, Germany. EBV IgMwas detected by
LIAISON, DiaSorin, Saluggia, Italy. Rheumatoid factor was
measuredbynephelometry using theNLatexRFkit, Siemens,
Marburg, Germany. Quantitative determinations of comple-
ment factor 3 and complement factor 4 in patients’ serawere
conducted using N antisera to human complement factor
reagents with Behring nephelometry (Siemens, Germany).
Statistical analysis
The Chi-square test was applied for categorical variables of
demographic data, clinical characteristics and serology. We
compared the interval between the onset of symptoms and
diagnosis (years) in adults and children by the Mann-
Whitney U test. Statistical significance was assumed for
p< 0.05. Values are expressed as means standard devia-
tion (SD).
Results
General characteristics
The study recruited 114 subjects (18 children, 96 adults).
Baseline demographics are summarized in Table 1. In the
children’s group, female patients were more common than
male patients with a ratio of 2.6, but in the adult group, the
proportion of females to males was similar. The difference
in sex ratio between the children and adult groups was
significant (p< 0.01). The mean age at onset in the children
and adults was 6.69 3.08 years and 51.57 20.88 years,
respectively. The mean age at diagnosis in children and
adults was 7.34 3.69 and 51.57 20.88 years, respec-
tively. The interval between the onset of symptoms and
diagnosis in children was longer than that in adults.Table 1 Demographic features of 114 cryoglobulinemia
patients
Children,
nZ 18
Adult,
nZ 96
p
Female / male ratio 13/5 47/49 <0.01
Mean (SD) age
at onset (yrs)
6.69 3.08 51.5 20.88
Mean (SD) age
at diagnosis (yrs)
7.34 3.69 52.23 18.81
Interval between
the onset of
symptoms and
diagnosis (yrs)
0.66 1.30 0.37 1.58 0.04Clinical symptoms
In children versus adults, there was a significantly higher
prevalence of prolonged fever (16.7% vs. 3.13%; pZ 0.018),
arthralgia (66.67% vs. 16.67%; p< 0.001), arthritis (66.67%
vs. 15.63%; p< 0.001) and cutaneous involvement (77.78%
v. 50%; pZ 0.03) (Table 2).
Associated or underlying disorders
The most common associated or underlying diseases in the
children and adult groups were essential cryoglobulinemia
(77.2% vs. 68.8%), followed by infection (16.7% vs. 33.3%)
and autoimmune diseases (16.7% vs. 17.7%). For both adults
and children, HBV infection (20.8% vs. 5.6%) was greater
than HCV (12.5% vs. 0%) infection (Table 3). Some associ-
ated diseases were found together. Specifically, it was
observed that HBV and hematologic disease (33.3% of non-
Hodgkin lymphoma) and autoimmune (5.9% of SS and 5.9%
of polymyositis) diseases sometimes affected the same
patient. We also found that only a few HBV patients (8.3%)
had HCV infection.
Immunologic features
There were no significant variations with regard to C3 and
C4 complement fractions and autoantibodies in both chil-
dren and adult groups (data not shown).
Clinical features between HBV and HCV groups
Among adults, one patient with both HBV and HCV infection
was excluded. In adult patients with HBV, the cutaneous
(42.11%) and liver (42.11%) were affected most frequently,
followed by renal involvement (21.05%) and peripheral
neuropathy (21.05%). In patients with HCV, the cutaneous
involvement (45.45%) was affected most frequently, fol-
lowed by leg ulcer (36.36%) and Raynaud phenomenon
(36.36%). A higher proportion of patients with HBVgroup,
nZ 18
nZ 96
Prolonged fever 3 (16.67) 3 (3.13) 0.018
Leg ulcer 3 (16.67) 18 (18.75) 0.834
Petechiae/Purpura 5 (27.78) 15 (15.63) 0.213
Arthralgia 12 (66.67) 16 (16.67) <0.001
Arthritis 12 (66.67) 15 (15.53) <0.001
Cutaneous involvement 14 (77.78) 48 (50.00) 0.030
Raynaud phenomenon 6 (33.33) 26 (27.08) 0.588
Peripheral neuropathy 3 (16.67) 19 (19.79) 0.758
Renal involvement 2 (11.11) 12 (12.50) 0.869
Liver involvement 3 (16.67) 10 (10.53) 0.454
Muscle weakness 0 9 (9.38) 0.176
DVT, arterial thrombosis 1 (5.56) 7 (8.33) 0.688
DVT Z deep vein thrombosis.
Table 3 Comparisons of associated or underlying diseases
between the children and adult groups
Event, n (%) Children Adult p
EC 13 (72.2) 66 (66.8) 0.504
Infection 3 (16.7) 32 (33.3) 0.128
HBV 1 (5.6) 20 (20.8) 0.109
HCV 0 12 (12.5) 0.113
EBV 1 (5.6) 0 0.158
Parvovirus 1 (5.6) 0 0.158
Autoimmune diseases 3 (16.7) 17 (17.7) 0.610
SLE 1 (5.6) 5 (5.2) 0.652
SS 1 (5.6) 5 (5.2) 0.652
JDM/DM 0 1 (1) 0.842
JPM/PM 0 1 (1) 0.842
JRA/RA 0 2 (2) 0.708
Anti-phospholipid syndrome 0 1 (1) 0.842
Henoch-Schonlein disease 1 (5.6) 0 0.158
Autoimmune thyroiditis 0 1 (1) 0.842
Malignancy 0 6 (6.2) 0.348
Leukemia 0 3 (3.1) 0.594
Lymphoma 0 2 (2) 0.708
Multiple myeloma 0 1 (1) 0.842
ECZ essential cryoglobulinemia; HBVZ hepatitis B virus; HCVZ
hepatitis C virus; EBV Z Epstein-Barr virus; SLE Z systemic
lupus erythematosus; SS Z Sjogren syndrome; JDM Z juvenile
dematomyositis; DM Z dermatomyositis; JPM Z juvenile poly-
myositis; PM Z polymyositis; JRA Z juvenile rheumatoid
arthritis; RAZ rheumatoid arthritis.
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36.36%; pZ 0.028) (Table 4).
Discussion
The clinical profiles were different between the children
and adult groups. In the adult group, the most frequent
clinical features at onset were cutaneous involvement,Table 4 Comparisons of clinical features between HBV
and HCV groups in adults
Event, n (%) HBV group HCV group p
Prolonged fever 2 (10.53) 0 (0.00) 0.265
Leg ulcer 1 (5.26) 4 (36.36) 0.028
Petechiae/purpura 2 (10.53) 3 (27.27) 0.236
Arthralgia 2 (10.53) 1 (9.09) 0.9
Arthritis 2 (10.53) 1 (9.09) 0.9
Cutaneous involvement 8 (42.11) 5 (45.45) 0.858
Raynaud phenomenon 3 (15.79) 4 (36.36) 0.199
Peripheral neuropathy 4 (21.05) 2 (18.18) 0.85
Renal involvement 4 (21.05) 0 (0.00) 0.102
Liver involvement 8 (42.11) 1 (9.09) 0.076
Muscle weakness 2 (10.53) 2 (18.18) 0.552
DVT, arterial thrombosis 1 (5.26) 1 (9.09) 0.685
The HBV group included 19 patients, and the HCV group
included 11 patients. HBV groupZ hepatitis B virus group; HCV
group Z hepatitis C virus group; DVT Z deep vein thrombosis.followed by Raynaud phenomenon and peripheral neurop-
athy. In contrast, in Western adults, purpura was the most
common presentation, followed by muscle weakness,
arthralgia, peripheral neuropathy and liver involvement.
The Raynaud phenomenon and arthritis were 36% and 8%,
respectively.2 We also found a low frequency of muscle
weakness in our adult cryoglobulinemic patients (9.38%),
which is different from that found by Ferri et al
(80e98%).2,23 In previous studies, the classical “Meltzer’s
triad” of purpura, arthralgias and weakness was seen in
25e30% of patients.12,24 In our patients, no cry-
oglobulinemic children had the classical triad, and only one
cryoglobulinemic adult (1.04%) had these symptoms.
In this cohort of children, we found that the most
frequent clinical symptoms were cutaneous involvement,
followed by arthritis, arthralgia, and Raynaud phenom-
enon. To date, there has not been a comparable study
worldwide. Cryoglobulinemic vasculitis is a multifactorial
disease. The causes of clinical diversities between our
study group and Caucasians may possibly result from
different ethnicity, sex, and mean age at diagnosis.
The most common etiologies were essential cry-
oglobulinemia, followed by infection and autoimmune
diseases in both children and adult groups. In Caucasian
adults, infection was the principal etiologic factor identi-
fied, followed by autoimmune diseases, essential cry-
oglobulinemia and hematologic diseases.10 Another study
demonstrated that essential cryoglobulinemia was the chief
etiology (71.6%), followed by chronic liver disease (11.7%),
lymphoproliferative disease (8.9%) and connective tissue
disease (5.4%).12
In this study, HBV was more common than HCV in cry-
oglobulinemic adults. In previous Western literature, the
incidence of HCV infection in mixed cryoglobulinemia
ranged from 40 to 90% and varied geographically.25,26
Although most cryoglobulinemia was associated with
chronic HCV infection, this association was reported
predominantly in countries with a high prevalence of HCV.27
HCV infection was the main infectious pathogen among
infections in 73%, and HBV constituted 3% of cry-
oglobulinemic patients.10 HBV infection is also an uncommon
cause of cryoglobulinemia in Caucasians.28 HBV carriers vary
from 0.1 to 2% in the United States, Canada, Western
Europe, Australia and New Zealand. However, in Taiwan,
Southeast Asia, China, and sub-Saharan Africa, there is
a high prevalence of HBV (10e20%).29,30 In a survey con-
ducted among Asian and Pacific island populations living
in New York City, 15% were positive for HBsAg, a proportion
much higher than the average US.31 Literature data
states that HBV represents an etiological factor of cry-
oglobulinemic vasculitis in a minority of individuals.2,10,32 In
chronic hepatitis B infections, cryoglobulins which contain
virus particles, heterogeneous antigen-antibody complexes
which have IgG and IgM, can be detected.33 By means of
the decrease in viral antigen and antibodies against them,
the amount of cryoglobulin probably decreases and symp-
toms of vasculitis regress.34 In prior studies, the symptoms
of vasculitis were resolved in patients with HBV-related
cryoglobulinemic vasculitis with the use of lamivudine by
itself or by its combination with interferon.34,35
The cutaneous involvement, leg ulcer, and Raynaud
phenomenon were the most frequent in the HCV group. The
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leg ulcers compared to the HBV group. The pathogenic
mechanisms of cryoglobulinemia may be different in both
groups. Even in Caucasians, patients with HCV related cry-
oglobulinemic vasculitis presented diverse clinical symptoms,
including more renal, cutaneous involvement,10 purpura,
arthralgia, peripheral neuropathy,36 livedo, distal ulcers,
gangrenous changes, or higher alanine aminotransferase.37
We analyzed the amount of overlap among the different
associated or underlying diseases. Specifically, we observed
a strong overlap between HBV infection and hematologic
(33% non-Hodgkin lymphoma) diseases. HBV infection had
few overlaps with HCV infection and autoimmune diseases.
In a prior study, there was a strong association between
HCV infection and some autoimmune (50% of SS, 67% of
polyarteritis nodosa) or hematologic (50% of non-Hodgkin
lymphoma) diseases.10 One study also found that most
patients with HBsAg (80%) or HIV infection (76%) also had
HCV infection.10
There are several limitations in this study. Firstly, our
laboratory use of qualitative analysis rather than quanti-
tative analysis.2 Secondly, few children and adults with
cryoglobulinemia had acute nephritis or nephrotic
syndrome, so it was not possible to compare these renal
diseases between the children and adult groups. Thirdly, 13
adult patients were excluded from our study owing to no
overt clinical characters, including positive cryoglobulin
serology. This isolated serology may be due to in the early
stages of the disease or during clinical remission.32,38,39
In conclusion, the clinical manifestation in both children
and adult groups were different. Children with cry-
oglobulinemia had a significantly higher prevalence of
prolonged fever, arthralgia, arthritis and cutaneous
involvement compared with adults with cryoglobulinemia.
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